IGFBP7 and MDK expressed by tumor cells and CAFs promote tumor progression and relapse by enhancing cancer stemness, EMT, extracellular matrix remodeling, and angiogenic activity [85–87]. This evidence concerns the gene IGFBP7 and cancer.